Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.
Front Immunol. 2023 Dec 20;14:1297577. doi: 10.3389/fimmu.2023.1297577. eCollection 2023.
Front Immunol. 2023.
PMID: 38187374
Free PMC article.
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Valko Z, Megyesfalvi Z, Schwendenwein A, Lang C, Paku S, Barany N, Ferencz B, Horvath-Rozsas A, Kovacs I, Schlegl E, Pozonec V, Boettiger K, Rezeli M, Marko-Varga G, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Grusch M, Laszlo V, Dome B, Schelch K.
Valko Z, et al. Among authors: schlegl e.
Br J Cancer. 2023 May;128(10):1850-1861. doi: 10.1038/s41416-023-02219-9. Epub 2023 Mar 14.
Br J Cancer. 2023.
PMID: 36918717
Free PMC article.
Item in Clipboard
[Predictive relevance of KRAS mutational status in bone metastatic lung adenocarcinoma treated with bisphosphonate therapy].
Radeczky P, Megyesfalvi Z, Fillinger J, László V, Rásó E, Moldvay J, Schlegl E, Barbai T, Bogos K, Tímár J, Rényi-Vámos F, Hegedűs B, Döme B.
Radeczky P, et al. Among authors: schlegl e.
Magy Onkol. 2021 Jun 3;65(2):103-111. Epub 2021 May 8.
Magy Onkol. 2021.
PMID: 34081758
Free article.
Hungarian.
Item in Clipboard
The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation.
Radeczky P, Megyesfalvi Z, Laszlo V, Fillinger J, Moldvay J, Raso E, Schlegl E, Barbai T, Timar J, Renyi-Vamos F, Dome B, Hegedus B.
Radeczky P, et al. Among authors: schlegl e.
Transl Lung Cancer Res. 2021 Feb;10(2):675-684. doi: 10.21037/tlcr-20-754.
Transl Lung Cancer Res. 2021.
PMID: 33718013
Free PMC article.
Item in Clipboard
Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas.
Papp E, Steib A, Abdelwahab EM, Meggyes-Rapp J, Jakab L, Smuk G, Schlegl E, Moldvay J, Sárosi V, Pongracz JE.
Papp E, et al. Among authors: schlegl e.
BMJ Open Respir Res. 2020 Jun;7(1):e000505. doi: 10.1136/bmjresp-2019-000505.
BMJ Open Respir Res. 2020.
PMID: 32527872
Free PMC article.
Item in Clipboard
KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy.
Ghimessy AK, Gellert A, Schlegl E, Hegedus B, Raso E, Barbai T, Timar J, Ostoros G, Megyesfalvi Z, Gieszer B, Moldvay J, Renyi-Vamos F, Lohinai Z, Hoda MA, Klikovits T, Klepetko W, Laszlo V, Dome B.
Ghimessy AK, et al. Among authors: schlegl e.
Cancers (Basel). 2019 Oct 9;11(10):1514. doi: 10.3390/cancers11101514.
Cancers (Basel). 2019.
PMID: 31600989
Free PMC article.
Item in Clipboard
Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making.
Schlegl E, Ducournau P, Ruof J.
Schlegl E, et al.
Pharmaceut Med. 2017;31(4):213-216. doi: 10.1007/s40290-017-0197-3. Epub 2017 Jul 11.
Pharmaceut Med. 2017.
PMID: 28824273
Free PMC article.
Item in Clipboard
Cite
Cite